Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Coronavirus trends – Equity strategy update
    • Opinion

    Coronavirus trends – Equity strategy update

    As we have previously written, investors need to keep an eye on company announcements for further clarity on near-term impact from COVID-19 as Feb-20 updates/commentary were largely redundant by the end of February. In this regard, we have been keeping up with the recent ASX company announcements across a diverse range of companies to get

    Read More
    Public
  • Travel ban bites as Virgin grounds 90% of fleet, stand down 80% of workforce
    • News

    Travel ban bites as Virgin grounds 90% of fleet, stand down 80% of workforce

    Following last night’s national address by Prime Minister Scott Morrison, introducing an overseas travel ban, Virgin Australia (ASX: VAH) has made the difficult decision to ground 125 of its aircraft and stand down 80 per cent of its workforce.  The move follows a similar one employed by Qantas (ASX: QAN) however, Virgin’s greater reliance on

    Read More
    Public
  • Some positives that may come from COVID-19
    • Opinion

    Some positives that may come from COVID-19

    I don’t want to downplay the seriousness of the coronavirus know as COVID-19, nor suggest that the economic impact won’t be severe. However, there is plenty of negative and sensational media you can consume around the virus and instead, I choose to write about some of the positives. They say that conflict breeds innovation, that

    Read More
    Public
  • The Coronavirus Vs. the Australian Dollar
    • Opinion

    The Coronavirus Vs. the Australian Dollar

    Due to the recent coronavirus pandemic sweeping the globe, James Hall reports that the Australian dollar has just hit a record low of 55 US cents – its lowest value in 18 years. In addition, the emergency interest rate was reduced to 0.25 percent by the Reserve Bank of Australia (RBA), which was a pending decision previously

    Read More
    Public
  • Retired NFL players endorse Zilosul, Paradigm’s osteoarthritis drug trials
    • News

    Retired NFL players endorse Zilosul, Paradigm’s osteoarthritis drug trials

    Professional athletes may soon have a new treatment for knee osteoarthritis after Paradigm Biopharmaceuticals (ASX: PAR) received glowing endorsements from two former NFL players undergoing the current round of Zilosul® treatment trials.  The trials of Zilosul® have been conducted on ten patients suffering from varying degrees of knee osteoarthritis under the Food and Drug Administration’s

    Read More
    Public
  • Ardent Leisure freefalls 86%, now shuts doors to all theme parks and venues
    • News

    Ardent Leisure freefalls 86%, now shuts doors to all theme parks and venues

    It will be school holidays like none before with the coronavirus national emergency prompting Ardent Leisure (ASX: ALG) to shut their theme parks which include Dreamworld and Whitewater World.  The decision comes after Ardent had endured significantly difficult trading conditions prior to the global outbreak of COVID-19 following the death of four patrons in 2016

    Read More
    Public
  • «
  • ‹
  • 621
  • 622
  • 623
  • 624
  • 625
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.